Amplity Health looking to grow in pharmaceutical commercialization market with support of Altamont Capital Partners
Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs
EVERSANA, while being formed, realized that its customers needed patient-centered, value-based care
Express Scripts Divesting United Biosource. Express Scripts and Avista Capital Partners, a leading private equity firm, recently announced that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding Company. Founded in 2003 and headquartered in Blue Bell, Pennsylvania, UBC is a leading provider of pharmaceutical and patient […]
Raising the Bar on performance So as to force companies to get lean, activist investors employ the use of shareholder arbitrage. There is increasing selection in licensing and partnering opportunities, and a reduced margin for error. Market-authorization for one-time results in periodic reevaluation throughout the life cycle of the product. There is relentlessness in the […]
Originally published at Pharmacy & Therapeutics – November 2014 http://www.nxtbook.com/nxtbooks/medimedia/pt_201411/src/forms/PT_November_2014_iframe_live.html#/38 Market and regulatory changes in the last 10 years, as well as the Affordable Care Act, have resulted in significant modifications to health care delivery models. Traditionally, P&T committees limited the impact of their decisions to the populations associated with their hospital or health plan; […]
It’s not just Health Care Reform that is turning the world of health care upside down. The cost shift to both the employee/consumer is dramatic and having an effect on sales. The old paradigm of success being defined as having Tier 2 access is no longer valid. The out of pocket burden for the employee/consumer […]
It’s not just Health Care Reform that is turning the world of health care upside down. The cost shift to both the employee/consumer is dramatic and having an effect on sales. The old paradigm of success being defined as having Tier 2 access is no longer valid. The out of pocket burden for the employee/consumer […]